Virginia is currently home to 1878 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Richmond, Charlottesville, Norfolk and Fairfax. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
NCT05433220
Recruiting
A randomized, single-blind intervention trial to test the comparative effectiveness of an electronic health record best practice advisory system that informs clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients with heart failure versus usual care (no alert and how things are done currently). The purpose of the alert is to stimulate appropriate medication prescription for patients with heart failure and a reduced ejection fractio... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/06/2023
Locations: Inova Health System, Falls Church, Virginia
Conditions: Heart Failure
Register for Updates
Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study
NCT05407389
Recruiting
This is an Open-Label Rollover Extension Clinical Trial to Evaluate the Long-Term Safety and Efficacy of KT-301 (formerly US-APR2020) in Subjects With CKD IV Who Completed the US-APR2020-01 Study
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
10/06/2023
Locations: Mendez Center for Clinical Research, Woodbridge, Virginia
Conditions: Chronic Kidney Disease stage4
Register for Updates
Saroglitazar Magnesium 4 mg for NASH in People Living With HIV in the US
NCT05211284
Recruiting
Saroglitazar Magnesium 4 mg for NASH in People Living with HIV in the US
Gender:
All
Ages:
18 years and above
Trial Updated:
10/06/2023
Locations: Zydus research site 8, Richmond, Virginia
Conditions: Nonalcoholic Steatohepatitis
Register for Updates
NEUROMARK Registry Study
NCT05937308
Recruiting
The NEUROMARK Registry Study is a prospective, multicenter, single-arm, post-market, interventional registry study to collect real-world evidence of the NEUROMARK System in subjects with chronic rhinitis.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/05/2023
Locations: Metropolitan ENT, Alexandria, Virginia
Conditions: Chronic Rhinitis
Register for Updates
Effectiveness of Remote Foot Temperature Monitoring
NCT05728411
Recruiting
Diabetic foot ulcers are common, debilitating, and costly complications of diabetes, disproportionately impacting Black and rural Veterans. Forty percent of individuals have an ulcer recurrence within a year of ulcer healing and 65% within 5 years. Monitoring plantar foot temperatures is one of the few interventions that reduces the risk of ulcer recurrence. Despite the evidence, adoption has been poor because the original procedures, including the use of handheld thermometers, were burdensome a... Read More
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
10/04/2023
Locations: Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia
Conditions: Diabetic Foot
Register for Updates
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion
NCT05245500
Recruiting
This is a Phase 1/2, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid tumor malignancy with homozygous deletion of the MTAP gene.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/03/2023
Locations: NEXT Virginia, Fairfax, Virginia
Conditions: Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors, Solid Tumor, Pancreatic Adenocarcinoma, Advanced Solid Tumor
Register for Updates
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
NCT05329103
Recruiting
This is a first-in-human, dose escalation, repeat-dose, multi-center, open-label study evaluating safety, tolerability, PK, and preliminary antitumor activity of PEEL-224 in patients with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/02/2023
Locations: NEXT Virginia, Fairfax, Virginia
Conditions: Advanced Solid Tumor
Register for Updates
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
NCT05482971
Recruiting
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon alfa-2b-njft (P1101) in Adult Patients with Essential Thrombocythemia
Gender:
All
Ages:
18 years and above
Trial Updated:
10/01/2023
Locations: University of Virginia - Emily Couric Cancer Center, Charlottesville, Virginia
Conditions: Essential Thrombocythemia
Register for Updates
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
NCT06065605
Recruiting
The purpose of this research is to collect biological samples (urine) to develop assays for immune biomarkers to possibly in the future be able to screen subjects with Fabry disease and be able to understand better progression of nephropathy in Fabry disease and predict nephropathy in Fabry disease.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
09/29/2023
Locations: Lysosomal & Rare Disorders Research & Treatment Center, Fairfax, Virginia
Conditions: Fabry Disease
Register for Updates
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
NCT05907980
Recruiting
This is a Phase Ia/Ib open-label, dose-escalation study to evaluate the safety and pharmacokinetics of ROSE12 as a single agent and in combination with other anti-tumor agents in patients with locally advanced or metastatic solid tumors. The study will consist of three parts: a dose-escalation part, a biopsy part (the part to evaluate biomarkers), and an expansion part.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/29/2023
Locations: NEXT Oncology, Fairfax, Virginia
Conditions: Solid Tumor
Register for Updates
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease
NCT05655520
Recruiting
The primary purpose of the study is to evaluate the safety and tolerability of SAGE-718 softgel lipid capsule in participants with Huntington's Disease (HD)
Gender:
All
Ages:
Between 25 years and 65 years
Trial Updated:
09/29/2023
Locations: Sage Investigational Site, Richmond, Virginia
Conditions: Huntington Disease
Register for Updates
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis
NCT05147220
Recruiting
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
09/29/2023
Locations: Novartis Investigative Site, Vienna, Virginia
Conditions: Relapsing Multiple Sclerosis
Register for Updates